Abstract
Purpose
The aim of our study was to evaluate factors influencing effectiveness of percutaneous microwave ablation (MWA) in patients with small hepatocellular carcinoma (HCC) (<3 cm).
Materials and methods
Between December 2007 and August 2015, 49 patients with 65 previously histological typed HCC were treated in a total of 61 sessions. Tumours were subdivided into central (>3 cm from the capsule) (n = 22) and peripheral (<3 cm from the capsule) (n = 43). Imaging follow-up was performed at 1, 3, 6, and 12 months after treatment, then annually. Mean follow-up period was 18 months (range 1–55). Location of the lesion, age, sex, and underlying disease of the patients was analyzed and related with efficacy.
Results
Technical success was obtained in all cases. Residual disease was registered in 21 lesions (32.3 %): 13 were peripheral and 8 were central. Twelve of them were retreated with percutaneous MWA. Local recurrence was recorded in 8 lesions (12.3 %): 5 were retreated with MWA. No significant difference in terms of effectiveness was observed in lesions located in a central position and those situated in the peripheral position. Age, sex, and underlying disease not influenced results. Only one major complication was observed. The rate of minor complications was 24.5 %. Mortality at 30 days was 0 %.
Conclusions
Our results encourage the role of MWA in the treatment of small HCC. More numerous series and randomized studies are necessary to state the role of MWA and to select cases in which MWA may be more effective and safer than RFA.
Similar content being viewed by others
References
Yamagiwa K, Shiraki K, Yamakado K, Mizuno S, Hori T, Yagi S et al (2008) Survival rates according to the Cancer of the Liver Italian Program scores of 345 hepatocellular carcinoma patients after multimodality treatments during a 10-year period in a retrospective study. J Gastroenterol Hepatol 23(3):482–490
Thandassery RB, Goenka U, Goenka MK (2014) Role of local ablative therapy for hepatocellular carcinoma. J Clin Exp Hepatol 4:S104–S111
Tan CH, Low SC, Thng CH (2011) APASL and AASLD consensus guidelines on imaging diagnosis of hepatocellular carcinoma: a review. Int J Hepatol 2011:519783
Bruix J, Sherman M (2011) AASLD practice guideline, management of hepatocellular carcinoma: an update. Hepatology 53(3):1020–1022
European Association For The Study Of The Liver, European Organization For Research And Treatment Of Cancer (2012) EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 56:908–943
Common Terminology Criteria for Adverse Events (CTCAE) Version 4.0 (2010). The National Cancer Institute, Bethesda Approved after October 1, 2009
Goldberg SN, Grassi CJ, Cardella JF, Charboneau JW, Dodd GD 3rd, Dupuy DE et al (2009) Image-guided tumor ablation: standardization of terminology and reporting criteria. J Vasc Interv Radiol 20:S377–S390
Rhim H, Dodd GD 3rd, Chintapalli KN, Wood BJ, Dupuy DE, Hvizda JL et al (2004) Radiofrequency thermal ablation of abdominal tumors: lessons learned from complications. Radiographics 24:41–52
Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247
Livraghi T, Meloni F, Di Stasi M, Rolle E, Solbiati L, Tinelli C et al (2008) Sustained complete response and complications rates after radiofrequency ablation of very early hepatocellular carcinoma in chirrosis: is resection still the treatment of choice? Hepatology 47:82–89
Huang J, Jan L, Cheng Z, Wu H, Du L, Wang J et al (2010) A randomized trial comparing radiofrequency ablationa and surgical resection for HCC conforming to the Milan criteria. Ann Surg 252:903–912
Chen MS, Li JQ, Zheng Y, Guo RP, Liang HH, Zhang YQ et al (2006) A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma. Ann Surg 243:321–328
Omata M, Lesmana LA, Tateishi R, Chen PJ, Lin SM, Yoshida H et al (2010) Asian Pacific Association for the Study of the Liver consensus recommendation on hepatocellular carcinoma. Hepatol Int 4:439–474
Kudo M, Izumi N, Kokudo N, Matsui O, Sakamoto M, Nakashima O et al (2011) HCC expert panel of Japan Society of Hepatology. Management of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated version. Dig Dis 29:339–364
Künzli BM, Abitabile P, Maurer CA (2011) Radio frequency ablation of liver tumors: actual limitations and potential solutions in the future. World J Hepatol 3:8–14
Wang ZL, Liang P, Dong BW, Yu XL, Yu DJ (2008) Prognostic factors and recurrence of small hepatocellular carcinoma after hepatic resection or microwave ablation: a retrospective study. J Gastrointest Surg 12:327–337
Poulou LS, Botsa E, Thanou I, Ziakas PD, Thanos L (2015) Percutaneous microwave ablation vs radiofrequency ablation in the treatment of hepatocellular carcinoma. World J Hepatol 7(8):1054–1063
Vogl TJ, Farshid P, Naguib NN, Zangos S, Bodelle B, Paul J et al (2015) Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation. Abdom Imaging 40(6):1829–1837
Francica G, Iodice G, Delle Cave M, Sarrantonio R, Lapiccirella G, Molese V et al (2007) Factors predicting complete necrosis rate after ultrasound-guided percutaneous laser thermoablation of smallhepatocellular carcinoma tumors in cirrhotic patients: a multivariate analysis. Acta Radiol 48(5):514–519
Mulier S, NiY, Iamart J, Ruers T, Marchal G, Michel R (2005) Local recurrence after hepatic radiofrequency coagulation: multivariate meta-analysis and review of contributing factors. Ann Surg 242(2):158–171
Poon RT, NgK K, Lam CM, Ai V, Yuen J, Fan ST, Wong J (2004) Learning curve for radiofrequency ablation of liver tumors: prospective analysis of initial 100 patients in a tertiary institution. Ann Surg 239:441–449
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
Informed consent
Informed consent was obtained from all individual participants included in the study.
Rights and permissions
About this article
Cite this article
Ierardi, A.M., Giorlando, F., Piacentino, F. et al. Factors predicting outcomes of microwave ablation of small hepatocellular carcinoma. Radiol med 122, 81–87 (2017). https://doi.org/10.1007/s11547-016-0694-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-016-0694-6